Research summary ·
Expression of the Chemokine (C-C Motif) Ligand 5 (CCL5) in Oral Lichen Planus and Oral Lichenoid Lesions: A Systematic Review.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This review looked at a protein called CCL5. CCL5 helps control how the body reacts with inflammation. The team asked if people with oral lichen planus have more of it. They also looked at people with similar mouth lesions, called lichenoid lesions. These people were compared with control groups. The team searched several study databases up to May 2026. They also rated the quality of each study.
What they found
The review included studies with 227 people in total. People with the disease had much higher CCL5 levels than controls. This was seen in the blood, in T cells, and in fibroblasts. But the authors say these results are weak. Many studies had a high risk of bias. The studies also differed a lot in methods and ways to diagnose the disease.
What it means for patients
The authors think CCL5 may play a part in causing this mouth disease. It may help draw T cells into the affected tissue. Higher CCL5 levels seemed to go along with worse disease. So the authors say CCL5 may be a possible target for treatment.
Why it is not certain yet
The authors say the evidence is of low quality. This is because most studies had a high risk of bias. Problems were seen in the stats, the reporting, and factors that could skew results. The studies also differed in methods and in how they diagnosed the disease. The authors say more research is needed to confirm the role of CCL5. A review can only be as good as the studies in it.
Source
Expression of the Chemokine (C-C Motif) Ligand 5 (CCL5) in Oral Lichen Planus and Oral Lichenoid Lesions: A Systematic Review.
PubMed · PMID 42394224We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Lichen planus publications